Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo - Aix-Marseille Université Access content directly
Journal Articles Neuro-Oncology Year : 2018

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

Benjamin Ellingson
  • Function : Author
Lauren Abrey
  • Function : Author
Josep Garcia
  • Function : Author
Olivier Chinot
Frank Saran
  • Function : Author
Ryo Nishikawa
  • Function : Author
Roger Henriksson
  • Function : Author
Warren Mason
  • Function : Author
Robert Harris
Kevin Leu
  • Function : Author
Davis Woodworth
  • Function : Author
Arnav Mehta
  • Function : Author
Catalina Raymond
  • Function : Author
Ararat Chakhoyan
  • Function : Author
Whitney Pope
  • Function : Author
Timothy Cloughesy
  • Function : Author

Dates and versions

hal-01858243 , version 1 (20-08-2018)

Identifiers

Cite

Benjamin Ellingson, Lauren Abrey, Josep Garcia, Olivier Chinot, Wolfgang Wick, et al.. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy064⟩. ⟨hal-01858243⟩
34 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More